𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid

✍ Scribed by Robert B Zurier; Ronald G Rossetti; Sumner H Burstein; Bonnie Bidinger

Book ID
113993371
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
162 KB
Volume
65
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of fibroblast metalloprotein
Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid
✍ David R. Johnson; Judith A. Stebulis; Ronald G. Rossetti; Sumner H. Burstein; Ro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract Production of matrix metalloproteinases (MMP) in joint tissue of patients with inflammatory arthritis facilitates cartilage degradation and bone erosion, and leads to joint deformities and crippling. Thus, MMPs are important targets for agents designed to treat inflammatory arthritis. O

Role of glucose in interleukin-1β produc
Role of glucose in interleukin-1β production by lipopolysaccharide-activated human monocytes
✍ Urszula Orlinska; Robert C. Newton 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 872 KB

## Abstract When monocytes are activated with endotoxin (lipopolysaccharide [LPS]), they make and release several mediators, including interleukin‐1β (IL‐1β). This study was undertaken to investigate the role of glucose in IL‐1β production by these cells. IL‐1β was produced in a dose‐dependent mann

Production of interleukin-1β by periodic
Production of interleukin-1β by periodic acid-oxidized human peripheral blood mononuclear cells
✍ George I. Malinin; Francis J. Hornicek; Theodore I. Malinin 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 475 KB

Interleukin-1 (IL-1) production by periodic acid (H5IO6)-oxidized human peripheral blood mononuclear (PBMN) cells was assessed by the thymocyte co-mitogenesis assay. Maximum IL-1 levels (approximately 1.2 U/ml) in the conditioned media of PBMN cells were registered within the first 24 hrs post-oxida